Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133542) titled 'Induction Chemotherapy Response-Adapted Stereotactic Body Radiotherapy and Immunotherapy in HPV-Associated Oropharyngeal Carcinoma' on Sept. 29.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Fudan University Shanghai Cancer Center
Condition:
HPV-positive oropharyngeal carcinoma
Intervention:
Group C:Stereotactic Body Radiation Therapy plus immunotherapy followed by de-intensified concurrent chemoradiotherapy.
Group B:Stereotactic Body Radiation Therapy followed by de-intensified radiotherapy.
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2025-02-10 ...